WASHINGTON, DC — A dramatic scene unfolded in the Oval Office during a White House press conference on Thursday when Gordon Findlay, Global Brand Director at Novo Nordisk, suddenly collapsed while President Donald Trump was addressing reporters.
The event was held to announce a new federal initiative with pharmaceutical companies Eli Lilly and Novo Nordisk to reduce the cost of obesity medications for millions of Americans. What began as a policy milestone quickly turned chaotic, with staff and attendees reacting to Findlay’s medical emergency.
“Video shows Gordon Findlay, Novo Nordisk Global Brand Director, losing his balance and collapsing beside the Resolute Desk while President Trump spoke.”
According to witnesses, Mehmet Oz, Administrator of the Centers for Medicare & Medicaid Services, immediately came to Findlay’s aid, preventing further injury. The press was ushered out of the room soon after the incident as medical personnel responded.
Robert F. Kennedy Jr., Secretary of Health and Human Services, was seen leaving the Oval Office shortly after the collapse, prompting discussion and speculation online regarding his reaction to the situation.
The press conference, led by President Trump, was organized to demonstrate collaboration between government officials and major pharmaceutical firms on public health affordability. The sudden medical emergency overshadowed the announcement but also highlighted the unpredictable nature of live political events.
Author’s summary: A White House event on prescription cost reform took an unexpected turn when Novo Nordisk’s Gordon Findlay collapsed, drawing attention to RFK Jr’s reaction and the quick emergency response.